Where Does Exagen Inc (XGN) Stock Fall in the Diagnostics & Research Field After It Is Higher By 27.56% This Week?

The 56 rating InvestorsObserver gives to Exagen Inc (XGN) stock puts it near the top of the Diagnostics & Research industry. In addition to scoring higher than 82 percent of stocks in the Diagnostics & Research industry, XGN’s 56 overall rating means the stock scores better than 56 percent of all stocks.

XGN has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on XGN!

See Full XGN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 56 means the stock is more attractive than 56 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Exagen Inc Stock Today?

Exagen Inc (XGN) stock is higher by 5.76% while the S&P 500 is lower by -0.22% as of 10:14 AM on Friday, Dec 1. XGN has gained $0.11 from the previous closing price of $1.88 on volume of 114,881 shares. Over the past year the S&P 500 is higher by 11.81% while XGN is lower by -24.33%. XGN lost -$1.86 per share the over the last 12 months. Click Here to get the full Stock Report for Exagen Inc stock.